Menu
GWAS Study

Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.

Wang M, Li Z, Chu H et al.

27206850 PubMed ID
GWAS Study Type
8051 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WM
Wang M
LZ
Li Z
CH
Chu H
LQ
Lv Q
YD
Ye D
DQ
Ding Q
XC
Xu C
GJ
Guo J
DM
Du M
CJ
Chen J
SZ
Song Z
YC
Yin C
QC
Qin C
GC
Gu C
ZY
Zhu Y
XG
Xia G
LF
Liu F
ZZ
Zhang Z
YL
Yuan L
FG
Fu G
HZ
Hu Z
TN
Tong N
SJ
Shen J
LK
Liu K
SJ
Sun J
SY
Sun Y
LJ
Li J
LX
Li X
SH
Shen H
XJ
Xu J
SY
Shi Y
ZZ
Zhang Z
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies (GWAS) of bladder cancer have identified a number of susceptibility loci in European populations but have yet to uncover the genetic determinants underlying bladder cancer incidence among other ethnicities. Therefore, we performed the first GWAS in a Chinese cohort comprising 3,406 cases of bladder cancer and 4,645 controls. We identified a new susceptibility locus for bladder cancer at 5q12.3, located in the intron of CWC27 (rs2042329), that was significantly associated with disease risk (OR = 1.40; P = 4.61 × 10(-11)). However, rs2042329 was not associated with bladder cancer risk in patients of European descent. The rs2042329 risk allele was also related to significantly increased expression levels of CWC27 mRNA and protein in bladder cancer tissues from Chinese patients. Additional functional analyses suggested that CWC27 played an oncogenic role in bladder cancer by inducing cell proliferation and suppressing apoptosis. In conclusion, the identification of a risk-associated locus at 5q12.3 provides new insights into the inherited susceptibility to bladder cancer in Chinese populations and may help to identify high-risk individuals. Cancer Res; 76(11); 3277-84. ©2016 AACR.

578 Han Chinese ancestry cases, 1,006 Han Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

8051
Total Participants
GWAS
Study Type
Yes
Replicated
2,828 Han Chinese ancestry cases, 3,639 Han Chinese ancestry controls
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.